John Haurum serves as the Chairman of the Board of Directors at CatalYm. In addition, John is a non-executive director of Adcendo, Agomab, Neophore, Solid Therapeutics, Storm and SynKlino. Previously, John served as CEO of F-star Therapeutics in Cambridge, England, and he held the position of Vice President, Research at ImClone Systems. He also co-founded and served as the CSO of Symphogen, Denmark. He holds a D.Phil. in Immunology from the University of Oxford and an MD from Aarhus University, Denmark.